1. Home
  2. AMR vs NVAX Comparison

AMR vs NVAX Comparison

Compare AMR & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alpha Metallurgical Resources Inc.

AMR

Alpha Metallurgical Resources Inc.

HOLD

Current Price

$183.27

Market Cap

2.0B

Sector

Energy

ML Signal

HOLD

Logo Novavax Inc.

NVAX

Novavax Inc.

HOLD

Current Price

$6.55

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMR
NVAX
Founded
2016
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Coal Mining
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.1B
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
AMR
NVAX
Price
$183.27
$6.55
Analyst Decision
Strong Buy
Hold
Analyst Count
3
9
Target Price
$168.00
$10.78
AVG Volume (30 Days)
248.7K
3.5M
Earning Date
11-06-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
2.07
Revenue
$2,226,356,000.00
$1,064,651,000.00
Revenue This Year
N/A
$58.91
Revenue Next Year
$17.77
N/A
P/E Ratio
N/A
$3.17
Revenue Growth
N/A
20.27
52 Week Low
$97.41
$5.01
52 Week High
$233.20
$11.55

Technical Indicators

Market Signals
Indicator
AMR
NVAX
Relative Strength Index (RSI) 59.93 39.20
Support Level $170.13 $6.57
Resistance Level $185.77 $6.84
Average True Range (ATR) 8.79 0.22
MACD 2.35 0.05
Stochastic Oscillator 79.71 28.00

Price Performance

Historical Comparison
AMR
NVAX

About AMR Alpha Metallurgical Resources Inc.

Alpha Metallurgical Resources Inc is a Tennessee-based coal mining company with operations across Virginia and West Virginia. The company's portfolio of mining operations consists of underground mines, surface mines, and coal preparation plants. It produces low-ash metallurgical coal, including High-Vol. A, Mid-Vol., High-Vol. B, and Low-Vol. coal, which is shipped to domestic and international coke and steel producers. The reportable segment of the company is Met. It extracts, processes and markets met and thermal coal from deep and surface mines for sale to steel and coke producers, industrial customers, and electric utilities.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

Share on Social Networks: